These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 35734167)

  • 1. Dynamics of Type I and Type II Interferon Signature Determines Responsiveness to Anti-TNF Therapy in Rheumatoid Arthritis.
    Iwasaki T; Watanabe R; Ito H; Fujii T; Okuma K; Oku T; Hirayama Y; Ohmura K; Murata K; Murakami K; Yoshitomi H; Tanaka M; Matsuda S; Matsuda F; Morinobu A; Hashimoto M
    Front Immunol; 2022; 13():901437. PubMed ID: 35734167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of molecules associated with response to abatacept in patients with rheumatoid arthritis.
    Yokoyama-Kokuryo W; Yamazaki H; Takeuchi T; Amano K; Kikuchi J; Kondo T; Nakamura S; Sakai R; Hirano F; Nanki T; Koike R; Harigai M
    Arthritis Res Ther; 2020 Mar; 22(1):46. PubMed ID: 32164778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon gene expression signature in rheumatoid arthritis neutrophils correlates with a good response to TNFi therapy.
    Wright HL; Thomas HB; Moots RJ; Edwards SW
    Rheumatology (Oxford); 2015 Jan; 54(1):188-93. PubMed ID: 25125592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.
    Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L
    Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early prediction of clinical response to anti-TNF treatment using multi-omics and machine learning in rheumatoid arthritis.
    Yoosuf N; Maciejewski M; Ziemek D; Jelinsky SA; Folkersen L; Müller M; Sahlström P; Vivar N; Catrina A; Berg L; Klareskog L; Padyukov L; Brynedal B
    Rheumatology (Oxford); 2022 Apr; 61(4):1680-1689. PubMed ID: 34175943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative expression and correlation of tumor necrosis factor-α, interferon-γ, and interleukin-17 in the rheumatoid synovium.
    Nakajima A; Aoki Y; Sonobe M; Watanabe F; Takahashi H; Saito M; Nakagawa K
    Clin Rheumatol; 2016 Jul; 35(7):1691-7. PubMed ID: 27038187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal analysis of blood DNA methylation identifies mechanisms of response to tumor necrosis factor inhibitor therapy in rheumatoid arthritis.
    Julià A; Gómez A; López-Lasanta M; Blanco F; Erra A; Fernández-Nebro A; Mas AJ; Pérez-García C; Vivar MLG; Sánchez-Fernández S; Alperi-López M; Sanmartí R; Ortiz AM; Fernandez-Cid CM; Díaz-Torné C; Moreno E; Li T; Martínez-Mateu SH; Absher DM; Myers RM; Molina JT; Marsal S
    EBioMedicine; 2022 Jun; 80():104053. PubMed ID: 35576644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synovial Inflammatory Pathways Characterize Anti-TNF-Responsive Rheumatoid Arthritis Patients.
    Wang J; Conlon D; Rivellese F; Nerviani A; Lewis MJ; Housley W; Levesque MC; Cao X; Cuff C; Long A; Pitzalis C; Ruzek MC
    Arthritis Rheumatol; 2022 Dec; 74(12):1916-1927. PubMed ID: 35854416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct Single Cell Gene Expression in Peripheral Blood Monocytes Correlates With Tumor Necrosis Factor Inhibitor Treatment Response Groups Defined by Type I Interferon in Rheumatoid Arthritis.
    Wampler Muskardin TL; Fan W; Jin Z; Jensen MA; Dorschner JM; Ghodke-Puranik Y; Dicke B; Vsetecka D; Wright K; Mason T; Persellin S; Michet CJ; Davis JM; Matteson E; Niewold TB
    Front Immunol; 2020; 11():1384. PubMed ID: 32765497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement in clinical disease activity index when treatment selection is informed by the tumor necrosis factor-ɑ inhibitor molecular signature response classifier: analysis from the study to accelerate information of molecular signatures in rheumatoid arthritis.
    Strand V; Zhang L; Arnaud A; Connolly-Strong E; Asgarian S; Withers JB
    Expert Opin Biol Ther; 2022 Jun; 22(6):801-807. PubMed ID: 35442122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomised controlled trial of tumour necrosis factor inhibitors against combination intensive therapy with conventional disease-modifying antirheumatic drugs in established rheumatoid arthritis: the TACIT trial and associated systematic reviews.
    Scott DL; Ibrahim F; Farewell V; O'Keeffe AG; Ma M; Walker D; Heslin M; Patel A; Kingsley G
    Health Technol Assess; 2014 Oct; 18(66):i-xxiv, 1-164. PubMed ID: 25351370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon signals and monocytic sensitization of the interferon-γ signaling pathway in the peripheral blood of patients with rheumatoid arthritis.
    Karonitsch T; von Dalwigk K; Steiner CW; Blüml S; Steiner G; Kiener HP; Smolen JS; Aringer M
    Arthritis Rheum; 2012 Feb; 64(2):400-8. PubMed ID: 21953607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between the type I interferon signature and the response to rituximab in rheumatoid arthritis patients.
    Thurlings RM; Boumans M; Tekstra J; van Roon JA; Vos K; van Westing DM; van Baarsen LG; Bos C; Kirou KA; Gerlag DM; Crow MK; Bijlsma JW; Verweij CL; Tak PP
    Arthritis Rheum; 2010 Dec; 62(12):3607-14. PubMed ID: 20722020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine and chemokine receptor profile of peripheral blood mononuclear cells during treatment with infliximab in patients with active rheumatoid arthritis.
    Nissinen R; Leirisalo-Repo M; Peltomaa R; Palosuo T; Vaarala O
    Ann Rheum Dis; 2004 Jun; 63(6):681-7. PubMed ID: 15140775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptome-wide study of TNF-inhibitor therapy in rheumatoid arthritis reveals early signature of successful treatment.
    Oliver J; Nair N; Orozco G; Smith S; Hyrich KL; Morgan A; Isaacs J; Wilson AG; ; Barton A; Plant D
    Arthritis Res Ther; 2021 Mar; 23(1):80. PubMed ID: 33691749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The elevated ratio of interferon gamma-/interleukin-4-positive T cells found in synovial fluid and synovial membrane of rheumatoid arthritis patients can be changed by interleukin-4 but not by interleukin-10 or transforming growth factor beta.
    Yin Z; Siegert S; Neure L; Grolms M; Liu L; Eggens U; Radbruch A; Braun J; Sieper J
    Rheumatology (Oxford); 1999 Nov; 38(11):1058-67. PubMed ID: 10556256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of a Type 2-Polarized T Cell Phenotype With Methotrexate Nonresponse in Patients With Rheumatoid Arthritis.
    Slauenwhite D; McAlpine SM; Hanly JG; Malik A; Haidl ID; Marshall JS; Issekutz TB
    Arthritis Rheumatol; 2020 Jul; 72(7):1091-1102. PubMed ID: 32039570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic signature of interferon-γ and interleurkin-17A in early rheumatoid arthritis.
    Lee K; Min HK; Koh SH; Lee SH; Kim HR; Ju JH; Kim HY
    Clin Exp Rheumatol; 2022 May; 40(5):999-1005. PubMed ID: 34369364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interferon type I signature towards prediction of non-response to rituximab in rheumatoid arthritis patients.
    Raterman HG; Vosslamber S; de Ridder S; Nurmohamed MT; Lems WF; Boers M; van de Wiel M; Dijkmans BA; Verweij CL; Voskuyl AE
    Arthritis Res Ther; 2012 Apr; 14(2):R95. PubMed ID: 22540992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The type I interferon signature in leukocyte subsets from peripheral blood of patients with early arthritis: a major contribution by granulocytes.
    de Jong TD; Lübbers J; Turk S; Vosslamber S; Mantel E; Bontkes HJ; van der Laken CJ; Bijlsma JW; van Schaardenburg D; Verweij CL
    Arthritis Res Ther; 2016 Jul; 18():165. PubMed ID: 27411379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.